- Report
- September 2024
- 200 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- February 2025
- 217 Pages
Global
From €3850EUR$4,050USD£3,235GBP
- Report
- January 2020
- 508 Pages
Global
From €4657EUR$4,899USD£3,913GBP
- Report
- February 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- February 2024
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2022
- 115 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- August 2022
- 116 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- December 2023
- 190 Pages
Global
€4749EUR$4,995USD£3,989GBP
- Report
- May 2023
- 99 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- May 2023
- 93 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- May 2023
- 92 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Book
- June 2017
- 424 Pages
- Book
- February 2016
- 1416 Pages
- Book
- March 2008
- 352 Pages

The Bone Marrow Transplant (BMT) market is a subset of the stem cell market. BMT is a medical procedure in which healthy stem cells are transplanted into a patient to replace damaged or diseased cells. The stem cells used in BMT are typically harvested from the patient's own bone marrow, or from a donor. BMT is used to treat a variety of conditions, including leukemia, lymphoma, and aplastic anemia.
The BMT market is highly competitive, with a number of companies offering products and services related to the procedure. These include companies that provide stem cell collection and processing services, as well as those that manufacture and distribute BMT-related products, such as cell culture media and reagents. Additionally, there are companies that specialize in providing BMT-related services, such as patient education and support.
Some of the major companies in the BMT market include StemCyte, LifeCell, and Osiris Therapeutics. Other notable companies include BioLife Solutions, Cellectis, and Thermo Fisher Scientific. Show Less Read more